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Introduction
Thorough investigation of the brain's wiring diagram is essential for understanding neural information processing at both local and global scales [1] . Exploring the structure and function of the brain's connectome is in fact one of the major scope of recent neuroscience research. However, new methods and technologies need to be developed to bridge brain structure and function [2] . Complementing neuronal recording with pathway tracing is still an indispensable tool to achieve such goals specifically at the microcircuit (single neurons) and mesoscale (neuronal populations) levels of the neural network. However, electrophysiology and neuronal tract tracing are usually applied separately even if combined in the same experiment. Typically if recording of neural activity is also needed, an additional electrode is positioned into the investigated brain area close to the micropipette or glass capillary used for neuronal labelling [3] . Similarly, the sequential application of electrode recording and tracer injection within the same experiment has several shortcomings including precision issues (targeting the same tissue volume), increased tissue damage by multiple penetrations, long preparation of electrode configurations. There are several drawbacks of such an approach including the precise alignment of the different electrodes/syringes, crowded instrumentation and the invasive manner of the surgery. Therefore a device integrating both microelectric recording and tract tracing capabilities is highly demanded to enhance efficiency and precision of such a multidisciplinary approach. Also, using integrated devices simplifies the experimental procedures and would perhaps increase the popularity of experiments combining physiological and anatomical approaches. Such progress could ultimately provide significant contribution in understanding the connectome [4] .
In vivo intra-and juxtacellular recordings are usually made by electrodes filled with substances as e.g. biocytin, allowing the subsequent anatomical reconstruction of the neurons. These are important tools in exploring the neuronal microcircuitry. However, recent development in the field of multielectrode recording (MUR) provides new opportunities in examining mesoscale, population level functional and structural (spatial patterns) phenomena. Also, understanding the neural basis of MUR related phenomena requires knowledge about the underlying neuronal connectivity. Anterograde and retrograde tracing techniques are fundamental means of connectional neuroanatomy [5] . There are numerous substances used for tracing with varying chemical properties (6] . Biotinylated dextran amine (BDA) is one of the most popular tracers because of its sensitivity and the ease of use for different purposes including fluorescence and electron microscopy. BDA is widely used for labeling the origin as well as the termination of neural connections [4] . High molecular weight BDA (<10 kDa) yields higher anterograde sensitivity and provides detailed labeling of axons and terminals (target regions), while low molecular weight BDA (>3 kDa) yields higher sensitivity and provides detailed retrograde labeling of neuronal cell bodies (origin of pathways) [4] . However, it should be noted that in some amount BDAs of different molecular weights are transported in both directions and that the preference of direction can be controlled for some extent with the experimental procedures applied (method of injection, combined neurochemical lesion with 5 NMDA, survival time etc.) [7] .
BDA has been used to trace connections both within the cerebral cortex and between cortical and subcortical structures of different species. BDA labelling revealed projections from numerous regions in the CNS, e.g. from the cortex to the substantia nigra [8] , from the brainstem [9] , medulla [10] , thalamus [7] etc. The two point source diffusion based real time techniques for drug delivery are iontophoresis and pressure ejection, both from a micropipette [11] . BDA can be applied both by pressure and iontophoresis. Iontophoresis is a fundamental technique to eject charged molecules including neuronal tracers in the brain tissue through establishing voltage gradient between the tracer solution suspended in a micropipette and the extracellular space. The advantage of iontophoresis over pressure injection is that ions and not the solution can be released in a modest amount by controlling the iontophoretic current [11] . The polarity of the applied current depends on the charge of the substance to be injected by iontophoresis. If there are no further charged molecules in the solution, then the amount of tracer deposited in the tissue is proportional to the total charge delivered by the current source. This implies that the electric current and injection time are the relevant parameters to be precisely controlled in an experiment. Mostly, pulsed direct current is used to prevent impedance build-up in micropipettes. One of the electrodes is a fine gauge wire which is inserted in the micropipette shaft. For this purpose, gold wire, silver wire, chloridized silver wire or stainless steel wire have been used. The other (reference) electrode is usually connected to some arbitrary site of the animal body, mostly outside of the brain tissue, providing a practically homogenous voltage gradient throughout the corpus of the animal.
In recent years, neural microelectrodes of several functionality have been developed and demonstrated [12] [13] [14] . For convection enhanced drug delivery purposes, a variety of microdevices has been successfully tested in vivo [15] [16] [17] [18] [19] . In our work, we propose an in vivo method of using neural microelectrode with monolithically integrated microfluidic channel to control tracer delivery in the close vicinity of the recording sites by iontophoresis. Additionally, we also prove that recording functionality is still facilitates the monitoring of local field potentials, single-and multiple unit activity. Detailed description of the device fabrication and application for convection enhanced delivery of drugs through the blood brain barrier can be found in our previous work [15] .
Experimental methods

Design & fabrication of the microfluidic channel and the microelectrodes
The fabrication of the microelectrode is based on standard silicon MEMS process described in this section. The fabrication process can be found in details in [15, 20] . First, the buried microchannel is fabricated then the functional layers and the probe shaft were micromachined. The initial substrate is a 380 µm thick (100) single-crystalline silicon wafer. Thermally grown dry silicon-dioxide and standard Microchem 1818 photoresist were used as a masking material for Si etching. Silicon dioxide was patterned in C 4 F 8 + O 2 plasma using reactive ion etching. Deep trench etching (Bosch process) in silicon was carried out in an Oxford Plasmalab System 100 6 chamber at room temperature. After removing the photoresist, an additional 100 nm thick SiO 2 was thermally grown on the substrate and on the trench walls. Electron beam evaporation of a 100 nm thick Al layer follows the oxidation, which acted as a protective coating during selective SiO 2 removal from the bottom of the trench. In order to remove the SiO 2 protective layer from the bottom of the trench, an anisotropic etch recipe using CHF 3 + Ar plasma chemistry is utilized. The formation of microchannels (isotropic Si etch) was carried out in SF6 plasma. In order to remove the sidewall protection, buffered HF was used for wet chemical etching of both Al and SiO 2 protection layers. After dehydration of the wafers at 300°C, an LPCVD process is applied for filling the microchannels and completely sealing the trenches by 1500 nm poly-Si deposition at 630°C. The formation of the buried microchannel is explained in more detail in [21] . Silicon wafers containing the buried microchannels were oxidized in wet atmosphere at 1100 °C in order to grow a 50nm thick thermal SiO 2 layer on the substrate surface. To further isolate the recording sites from the bulk Si, a 300nm thick low-stress silicon nitride (SiN x ) film was then deposited on top of the SiO 2 by LPCVD at 830 °C. A sacrificial Al layer was used to define the pattern of the TiO x /Pt recording sites and conductor paths via a standard lift-off process. First, the 300nm thick sacrificial Al layer was deposited by electron beam evaporation. This was followed by the first photolithography and etching steps defining the inverse pattern of the conductor path. The conductor layer consisted of a 15 nm thick adhesion layer of TiO x formed by reactive sputtering of Ti in an Ar/O 2 atmosphere. In the same vacuum cycle, 270 nm thick Pt was sputtered on top of TiO x . The photoresist together with the overlying TiO x /Pt layer was removed using acetone. The Al layer was etched away as before, to complete with the liftoff process. In the next step the upper passivation stack is formed, 300 nm thick SiO 2 and SiN x layers were deposited using LPCVD at 430 °C and 830°C, respectively. Contact and bonding sites were defined by additional photolithography step followed by selective SiO 2 and SiN x wet etching process in NH 4 F buffered HF and phosphorous acid until the total removal of the oxide and nitride layers. The probe shaft and inlet reservoirs were micromachined by dry etching using Bosch recipe in an Oxford Plasmasab System 100 DRIE chamber. Masking layer was standard photoresist on the front side, while the etch stop layers were electron beam evaporated Al film and subsequently spin-coated photoresist. The fabrication process can be found in more details in [15, 20] .
The monolithically integrated microfluidic channel is 15 mm long, and 314 μm 2 in cross-section. The fluidic outlets are on the side of the probe as presented on Fig. 1 .a. The counter Pt electrode is 900 μm 2 and the distance between the fluidic outlet and the Pt counter electrode is 125 μm. Schematic layout of the probe tip is shown in Fig 1. b. The fluidic interfacing to the probe is described in our previous work in details [15] .
Surgery
Animal care and experiments were performed in compliance with Animal Care Regulations of the Institute for Psychology of the Hungarian Academy of Sciences and order 243/1988 of the Hungarian Government, which is an adaptation of directive 86/609/EGK of the European Committee Council. The animals were initially anesthetized via intraperitoneal injection of a mixture of 37.5 mg/ml ketamine and 5 mg/ml xylazine at 0.3 ml/100 g body weight injection volume. The sleeping state was maintained by intramuscular updates of the same solution. A drop of paraffin oil was applied in each eye of a rat in order to prevent them from drying. The anesthetized animal was placed into a stereotactic frame (David Kopf Instruments, Tujunga, CA, USA), head-restrained. The scalp and other soft tissues, including the periosteum covering the skull were removed with a scalpel. Craniotomy window was opened above the parietal lobe. The dura mater was incised and removed with a sharp needle. Also, the arachnoid membrane and the pia mater were gently poked with a fine needle tip.
In vivo extracellular recording
Electrophysiological recording was performed following the iontophoretic injections. At the same location, the probe was utilized for multichannel extracellular recording, using a twostage amplifier and a data acquisition system with a gain of 1000, 20 kHz sampling rate and 16 bit resolution (LabView, National Instruments Corp., Austin, TX, USA) [22] . Edit 4.5 software of Neuroscan (Charlotte, NC, USA) was used for off-line signal visualization, filtering and analysis. The Klusters free software was used for clustering unit activities [23] .
Iontophoretic injection of BDA
In six cases (REF, LF1, MF1, MF2, HF1, HF2) a 1:1 mixture of high and low molecular weight 10% BDA (MW 10.000 and 3000, final cc 5 % each) (Molecular Probes, Inc. Eugene, OR, USA) dissolved in 0.01M phosphate buffer (pH 7.4) were used. These studies were evaluated through histology examinations only (see Table 1 ). In three further cases (REF2, PR, PRELFIZ)we used only the BDA 10K in 10% to test neuronal labeling followed by electrical recording through the same device (see Table 2 .).The fluidic channel was filled with the BDA solution prior to the surgery. The counter Pt electrode, one among the recording sites of the multielectrode array (MEA) near to the opening of the channel on the shaft, was negatively biased relative to the channel containing the BDA, while the electrical current was measured. A positively biased silver electrode was placed into the fluidic channel to repel the positively charged BDA molecules out of the drug delivery channel. A control experiment was carried out without any voltage bias (injector turned off) allowing passive diffusion between the microfluidic channel and the extracellular space. Each injection lasted for 15 minutes and was applied by varying the length of the on/off cycle and the current amplitude. Injections were made at different depths (660-1440 µm) depending on electrode configurations (Table 3) .
Perfusion
After 7 days survival period, animals were deeply anesthetized before perfusing transcardially with 300 ml of 0.9 % NaCl in distilled water and 500 ml fixative consisted of 4% 
Histology and microscopy
Following dissection of the region of interest, serial sections were cut at 60 μm either in the horizontal (cases REF, MF1, MF2, HF1, HF2, LF1) or in the coronal plane (cases REF2, PR, PRELFIZ) with a vibratome. The standard ABC protocol (Elite kit, Vector Laboratories, Inc. Burlingame, CA, USA) was used to visualize BDA labeling with Nickel enhanced diaminobenzidin (Ni-DAB) (Sigma-Aldrich Kft, Budapest, Hungary) as the chromogen. In short, sections were rinsed in 0.1 M PB and first treated with 0.5% Triton-X 100 (Reanal Zrt., Budapest, Hungary) in 0.1 M PB for 30 minutes. After a several washes in 0.1 M PB, intrinsic peroxidase activity was blocked by 1% H 2 O 2 in PB (30 min) before the ABC step. The sections were incubated with the avidin/biotinylated enzyme complex (ABC, 1:200 in PB, 0.1M, pH 7.4) for 2 hours at room temperature and washed thoroughly. After the Ni-DAB reaction the sections were mounted on gelatinated slides and cover slipped with Depex (Serva Electrophoresis GmbH, Heidelberg, Germany).Images were collected with an Olympus research microscope equipped with a motorized stage (MultiControl 2000, Märzhäuser Wetzlar GmbH & Co. KG, Wetzlar, Germany) using the 2D Virtual Tissue module of Neurolucida® (Micro Bright Field Europe, E.K. Magdeburg, Germany). Except some enhancement of the contrast and brightness microscopic images were not edited.
Results & Discussion
Several successful iontophoretic injection were carried out using the microfluidic channel of the neural microelectrode. The implantation of the microelectrodes resulted in some tissue damage at the injection site, which however, apparently did not affect the injection and transport of BDA. In general, the applied mixture of high and low molecular weight BDA provided a clear labeling of neuronal cell bodies and terminals that are present in the vicinity of the implantation track. A representative microscopic view of a labeled neuron is shown in Figure 2 .c. BDA labeled neurons were clearly recognizable at the site of injection, which was devoid of a strong diffuse background labeling.
Control experiment
To avoid any artifacts in our measurements, we carried out control in vivo experiments to reveal the extent of diffusion of the tracer molecules through the outlet of the fluidic channel.
Comparison of the control experiment and the iontophoretic injection is shown in Figure 2 and Figure 3 . In the control case, where no current was used we did not find any labeled structures. In case of iontophoresis, we found anterogradely labeled axons and retrogradely labeled neurons. Although, in bidirectional tracing we have to consider the possibility of axonal backfilling in retrogradely labeled neurons, which could be mistakenly identified as anterograde labeling from the injection site. However, we found dense axonal labeling distant from retrogradely labeled neurons, which suggest that our bidirectional tracing worked effectively. More detailed discussion of this methodological issue can be found in [7] .
Effect of the injection parameters on BDA labeling
Detectable BDA labeling was observed only when applying current amplitude, length of the on/off cycle and total injection time described by previous studies using glass capillary electrodes [7] . Accordingly, 3-5 µA, 5-7 s on/off cycle and 15-20 min total injection time resulted in nice anterograde and retrograde BDA labeling both within the cortex as well as in subcortical structures. Interestingly, injection sites appeared very clear lacking the strong diffuse labeling characterizing the core region of iontophoretic injections and only a thin halo area was observed (Figure 2 , see Table 3 ). No noticeable difference was observed in the BDA labeling when using the different types of electrode configurations. Figure 4 shows examples of anterograde and retrograde BDA labeling in distant cortical and subcortical areas including the ipsilateral cortico-cortical, callosal and thalamic connections. In another case in Figure 5 , we show the laminar columnar organization of long distance lateral cortical connections. In all cases both anterograde and retrograde labeling revealed the fine details of neuronal processes including dendritic spines and axon terminal-like endings (Figs.  1C-F, 2C,D) .
Mapping the projectome of the primary somatosensory cortical trunk region by BDA
Recording of neural activity
The probes were suitable for the detection of neurophysiological signals. Figure 6 shows samples of recordings, obtained after iontophoretic tracer release. The probe was slowly extracted from the tissue with 800 µm steps. After the second step, its proximal site reached the brain surface. High quality local field potential, single and multiple unit activities could be measured. Figure 7 A and B shows examples for single units (spikes), detected at the place of the tracer release and 800 µm above it, respectively.
Perspective of applications
In vivo iontophoresis in the central nervous system is mostly applied to deliver dyes and pathway tracers for subsequent histological studies [4, 7, 23] or to investigate the effect of drugs on neuronal activity [24] [25] [26] . These studies relies on the application of pulled glass micropipettes [24] [25] or multi-barreled carbon fiber electrodes [27] [28] . The combined use of iontophoresis and single cell electrophysiology is apparently necessary in these neuropharmacological studies, however, potential measurements are only based on one recording site only. Our proposed device facilitates the parallel use of local iontophoresis and multi-electrode recording offering the observation of multiple neurons or neuronal populations along the probe track with limited tissue damage. Besides pathway tracing, we envision to exploit such advantage in fundamental behavioural animal studies in the future as well.
Conclusion
In this paper, the successful application of a monolithically integrated microfluidic channel in a neural microelectrode for local iontophoretic drug delivery and neuronal labeling is demonstrated in vivo. The localized injection using 3-5 µA, 5-7 s on/off cycle and 15-20 min total injection time resulted in clear anterograde and retrograde BDA labeling both within the cortex as well as in subcortical structures providing the projectome of the primary somatosensory cortical trunk area. In all cases, both anterograde and retrograde labeling revealed the fine details of neuronal processes including dendritic spines and axon terminal-like endings. Injection sites appeared very clear lacking the strong diffuse labeling characterizing the core region of iontophoretic injections and only a thin halo area was observed. No BDA labeling was found in control experiments, where the iontophoresis device was not turned on. Combined tracer injection and electrophysiology is presented in anaesthized animals using the very same microprobe. Tracer injection did not result in abnormal cortical functioning examined by electrophysiological recordings. Since the proposed device is feasible to serve combined labeling and electrophysiology studies with precisely (micron resolution) defined fluidic outlet and recording site relative positioning, we envision further applications like neural microcircuit and projectome mapping in animal studies. 
